Skip to main content
Erschienen in: Der Pathologe 4/2017

20.04.2017 | Lymphome | Schwerpunkt: Kinderpathologie

„Echte Thymushyperplasie“

Differenzialdiagnose der Thymusvergrößerung bei Säuglingen und Kindern

verfasst von: Dr. C.‑A. Weis, B. Märkl, T. Schuster, K. Vollert, P. Ströbel, A. Marx

Erschienen in: Die Pathologie | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Reaktive und neoplastische Veränderungen des Thymus stehen im Zentrum der Differenzialdiagnose bei tumorartigen Veränderungen des vorderen und mittleren Mediastinums, während bei Tumoren des hinteren Mediastinums besonders an neurogene Neoplasien zu denken ist (die hier nicht behandelt werden). Bei Neugeborenen und Säuglingen stellen Keimzelltumoren, kongenitale Zysten und „echte Thymushyperplasien“, die häufigsten Veränderungen im vorderen Mediastinum dar. Bei Kleinkindern dominieren Teratome vor Dottersacktumoren und Zysten. Bei älteren Kindern und Jugendlichen sind Lymphome am prävalentesten, während Thymuskarzinome und Thymome Raritäten sind. Zusätzlich sind dann auch entzündlich bedingt Thymushyperplasie bei Myasthenia gravis und „Überschusshyperplasien“ des Thymus z. B. nach Chemotherapie zu bedenken. Sarkome sind ab der Geburt seltene aber wichtige Differenzialdiagnosen. Ausgehend von der Schilderung eines seltenen Falls einer rezidivierten „echten Thymushyperplasie“ wird die Differenzialdiagnose dieser nichtneoplastischen aber potenziell lebensbedrohlichen Erkrankung diskutiert.
Literatur
1.
Zurück zum Zitat Berrih-Aknin S, Ruhlmann N, Bismuth J et al (2009) CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 66:521–531CrossRefPubMed Berrih-Aknin S, Ruhlmann N, Bismuth J et al (2009) CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 66:521–531CrossRefPubMed
2.
Zurück zum Zitat Chertoff J, Barth RA, Dickerman JD (1991) Rebound thymic hyperplasia five years after chemotherapy for Wilms’ tumor. Pediatr Radiol 21:596–597CrossRefPubMed Chertoff J, Barth RA, Dickerman JD (1991) Rebound thymic hyperplasia five years after chemotherapy for Wilms’ tumor. Pediatr Radiol 21:596–597CrossRefPubMed
3.
Zurück zum Zitat Chuang WY, Strobel P, Bohlender-Willke AL et al (2014) Late-onset myasthenia gravis – CTLA4(low) genotype association and low-for-age thymic output of naive T cells. J Autoimmun 52:122–129CrossRefPubMed Chuang WY, Strobel P, Bohlender-Willke AL et al (2014) Late-onset myasthenia gravis – CTLA4(low) genotype association and low-for-age thymic output of naive T cells. J Autoimmun 52:122–129CrossRefPubMed
4.
Zurück zum Zitat Dalla Costa M, Mangano FA, Betterle C (2014) Thymic hyperplasia in patients with Graves’ disease. J Endocrinol Invest 37:1175–1179CrossRefPubMed Dalla Costa M, Mangano FA, Betterle C (2014) Thymic hyperplasia in patients with Graves’ disease. J Endocrinol Invest 37:1175–1179CrossRefPubMed
5.
Zurück zum Zitat Den Bakker MA, Oosterhuis JW (2009) Tumours and tumour-like conditions of the thymus other than thymoma; a practical approach. Histopathology 54:69–89CrossRef Den Bakker MA, Oosterhuis JW (2009) Tumours and tumour-like conditions of the thymus other than thymoma; a practical approach. Histopathology 54:69–89CrossRef
6.
Zurück zum Zitat Eifinger F, Ernestus K, Benz-Bohm G et al (2007) True thymic hyperplasia associated with severe thymic cyst bleeding in a newborn: case report and review of the literature. Ann Diagn Pathol 11:358–362CrossRefPubMed Eifinger F, Ernestus K, Benz-Bohm G et al (2007) True thymic hyperplasia associated with severe thymic cyst bleeding in a newborn: case report and review of the literature. Ann Diagn Pathol 11:358–362CrossRefPubMed
7.
Zurück zum Zitat Farruggia P, Trizzino A, Scibetta N et al (2011) Castleman’s disease in childhood: report of three cases and review of the literature. Ital J Pediatr 37:50CrossRefPubMedPubMedCentral Farruggia P, Trizzino A, Scibetta N et al (2011) Castleman’s disease in childhood: report of three cases and review of the literature. Ital J Pediatr 37:50CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ferri C, Colaci M, Battolla L et al (2006) Thymus alterations and systemic sclerosis. Rheumatology (Oxford) 45:72–75CrossRef Ferri C, Colaci M, Battolla L et al (2006) Thymus alterations and systemic sclerosis. Rheumatology (Oxford) 45:72–75CrossRef
9.
Zurück zum Zitat French C, Den Bakker M (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 229–231 French C, Den Bakker M (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 229–231
10.
Zurück zum Zitat Gaiser T, Haedicke W, Becker MR (2010) A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma. Int J Clin Exp Pathol 3:437–442PubMedPubMedCentral Gaiser T, Haedicke W, Becker MR (2010) A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma. Int J Clin Exp Pathol 3:437–442PubMedPubMedCentral
11.
Zurück zum Zitat Gradolatto A, Nazzal D, Truffault F et al (2014) Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun 52:53–63CrossRefPubMed Gradolatto A, Nazzal D, Truffault F et al (2014) Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun 52:53–63CrossRefPubMed
12.
Zurück zum Zitat Gregersen PK, Kosoy R, Lee AT et al (2012) Risk for myasthenia gravis maps to a (151) Pro–〉Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72:927–935CrossRefPubMedPubMedCentral Gregersen PK, Kosoy R, Lee AT et al (2012) Risk for myasthenia gravis maps to a (151) Pro–〉Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72:927–935CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hofmann WJ, Moller P, Otto HF (1987) Thymic hyperplasia. I. True thymic hyperplasia. Review of the literature. Klin Wochenschr 65:49–52CrossRefPubMed Hofmann WJ, Moller P, Otto HF (1987) Thymic hyperplasia. I. True thymic hyperplasia. Review of the literature. Klin Wochenschr 65:49–52CrossRefPubMed
14.
Zurück zum Zitat Hofmann WJ, Moller P, Otto HF (1987) Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study. Klin Wochenschr 65:53–60CrossRefPubMed Hofmann WJ, Moller P, Otto HF (1987) Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study. Klin Wochenschr 65:53–60CrossRefPubMed
15.
Zurück zum Zitat Hohlfeld R, Wekerle H (2008) Reflections on the “intrathymic pathogenesis” of myasthenia gravis. J Neuroimmunol 201–202:21–27CrossRefPubMed Hohlfeld R, Wekerle H (2008) Reflections on the “intrathymic pathogenesis” of myasthenia gravis. J Neuroimmunol 201–202:21–27CrossRefPubMed
16.
Zurück zum Zitat Jegalian AG, Bodo J, Hsi ED (2015) NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T‑lymphoblastic lymphoma from thymoma. Am J Surg Pathol 39:565–572CrossRefPubMed Jegalian AG, Bodo J, Hsi ED (2015) NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T‑lymphoblastic lymphoma from thymoma. Am J Surg Pathol 39:565–572CrossRefPubMed
17.
Zurück zum Zitat Jeon TJ, Lee YS, Lee JH et al (2014) Rebound thymic hyperplasia detected by 18 F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer. Thyroid 24:1636–1641CrossRefPubMedPubMedCentral Jeon TJ, Lee YS, Lee JH et al (2014) Rebound thymic hyperplasia detected by 18 F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer. Thyroid 24:1636–1641CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Judd RL (1987) Massive thymic hyperplasia with myoid cell differentiation. Hum Pathol 18:1180–1183CrossRefPubMed Judd RL (1987) Massive thymic hyperplasia with myoid cell differentiation. Hum Pathol 18:1180–1183CrossRefPubMed
19.
Zurück zum Zitat Kissin CM, Husband JE, Nicholas D et al (1987) Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology 163:67–70CrossRefPubMed Kissin CM, Husband JE, Nicholas D et al (1987) Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology 163:67–70CrossRefPubMed
20.
Zurück zum Zitat Lack EE (1981) Thymic hyperplasia with massive enlargement: report of two cases with review of diagnostic criteria. J Thorac Cardiovasc Surg 81:741–746PubMed Lack EE (1981) Thymic hyperplasia with massive enlargement: report of two cases with review of diagnostic criteria. J Thorac Cardiovasc Surg 81:741–746PubMed
21.
Zurück zum Zitat Marx A, Chan JK, Coindre JM et al (2015) The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol 10:1383–1395CrossRefPubMedPubMedCentral Marx A, Chan JK, Coindre JM et al (2015) The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol 10:1383–1395CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Marx A, Pfister F, Schalke B et al (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875–884CrossRefPubMed Marx A, Pfister F, Schalke B et al (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875–884CrossRefPubMed
23.
Zurück zum Zitat Menter T, Gasser A, Juskevicius D et al (2015) Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Appl Immunohistochem Mol Morphol 23:491–498CrossRefPubMed Menter T, Gasser A, Juskevicius D et al (2015) Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Appl Immunohistochem Mol Morphol 23:491–498CrossRefPubMed
24.
Zurück zum Zitat Meyer A, Levy Y (2010) Geoepidemiology of myasthenia gravis [corrected. Autoimmun Rev 9:A383–A386CrossRefPubMed Meyer A, Levy Y (2010) Geoepidemiology of myasthenia gravis [corrected. Autoimmun Rev 9:A383–A386CrossRefPubMed
25.
Zurück zum Zitat Middleton G, Schoch EM (2000) The prevalence of human thymic lymphoid follicles is lower in suicides. Virchows Arch 436:127–130CrossRefPubMed Middleton G, Schoch EM (2000) The prevalence of human thymic lymphoid follicles is lower in suicides. Virchows Arch 436:127–130CrossRefPubMed
26.
Zurück zum Zitat Moreira A, Chan J, Looijenga L et al (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 244–248 Moreira A, Chan J, Looijenga L et al (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 244–248
27.
Zurück zum Zitat Naithani R, Ngan BY, Roifman C et al (2012) Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girl. J Pediatr Hematol Oncol 34:552–555CrossRefPubMed Naithani R, Ngan BY, Roifman C et al (2012) Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girl. J Pediatr Hematol Oncol 34:552–555CrossRefPubMed
28.
Zurück zum Zitat Nicholson AG, Detterbeck F, Marx A et al (2017) Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 70:522–538CrossRefPubMed Nicholson AG, Detterbeck F, Marx A et al (2017) Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 70:522–538CrossRefPubMed
29.
Zurück zum Zitat Priola AM, Priola SM (2014) Chemical-shift MRI of rebound thymic hyperplasia with unusual appearance and intense (18)F-FDG uptake in adulthood: report of two cases. Clin Imaging 38:739–742CrossRefPubMed Priola AM, Priola SM (2014) Chemical-shift MRI of rebound thymic hyperplasia with unusual appearance and intense (18)F-FDG uptake in adulthood: report of two cases. Clin Imaging 38:739–742CrossRefPubMed
31.
Zurück zum Zitat Scadding GK, Vincent A, Newsom-Davis J et al (1981) Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 31:935–943CrossRefPubMed Scadding GK, Vincent A, Newsom-Davis J et al (1981) Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 31:935–943CrossRefPubMed
32.
Zurück zum Zitat Shin MS, Ho KJ (1983) Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin’s disease. An immunologic rebound phenomenon? Cancer 51:30–33CrossRefPubMed Shin MS, Ho KJ (1983) Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin’s disease. An immunologic rebound phenomenon? Cancer 51:30–33CrossRefPubMed
33.
Zurück zum Zitat Skeie GO, Romi F (2008) Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 15:1029–1033CrossRefPubMed Skeie GO, Romi F (2008) Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 15:1029–1033CrossRefPubMed
34.
Zurück zum Zitat Ströbel P, Badve S et al (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 187–192 Ströbel P, Badve S et al (2015) WHO classification of tumours of the lung, pleura, thymus and heart. In: Travis W, Brambilla E, Burke A, Marx A, Nicholson A (Hrsg) WHO classification of tumours. IARC, Lyon, S 187–192
35.
Zurück zum Zitat Strobel P, Moritz R, Leite MI et al (2008) The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol 201–202:64–73CrossRefPubMed Strobel P, Moritz R, Leite MI et al (2008) The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol 201–202:64–73CrossRefPubMed
36.
Zurück zum Zitat Strobel P, Murumagi A, Klein R et al (2007) Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 211:563–571CrossRefPubMed Strobel P, Murumagi A, Klein R et al (2007) Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 211:563–571CrossRefPubMed
37.
Zurück zum Zitat Sun DP, Wang L, Ding CY et al (2016) Investigating factors associated with thymic regeneration after chemotherapy in patients with lymphoma. Front Immunol 7:654PubMedPubMedCentral Sun DP, Wang L, Ding CY et al (2016) Investigating factors associated with thymic regeneration after chemotherapy in patients with lymphoma. Front Immunol 7:654PubMedPubMedCentral
38.
Zurück zum Zitat Suster S, Barbuto D, Carlson G et al (1991) Multilocular thymic cysts with pseudoepitheliomatous hyperplasia. Hum Pathol 22:455–460CrossRefPubMed Suster S, Barbuto D, Carlson G et al (1991) Multilocular thymic cysts with pseudoepitheliomatous hyperplasia. Hum Pathol 22:455–460CrossRefPubMed
39.
Zurück zum Zitat Tabarin A, Catargi B, Laurent F et al (1993) Paraneoplastic Cushing’s syndrome. Pseudotumors of the thymus occurring after correction of hypercorticism. 3 cases. Presse Med 22:1908–1910 (S 1915)PubMed Tabarin A, Catargi B, Laurent F et al (1993) Paraneoplastic Cushing’s syndrome. Pseudotumors of the thymus occurring after correction of hypercorticism. 3 cases. Presse Med 22:1908–1910 (S 1915)PubMed
40.
Zurück zum Zitat Tani T, Okumura F, Nakamura A et al (1994) A case of true thymic hyperplasia showing slow growth as revealed by chest X‑ray. Nihon Kyobu Shikkan Gakkai Zasshi 32:194–198PubMed Tani T, Okumura F, Nakamura A et al (1994) A case of true thymic hyperplasia showing slow growth as revealed by chest X‑ray. Nihon Kyobu Shikkan Gakkai Zasshi 32:194–198PubMed
41.
Zurück zum Zitat Vincent A, Scadding GK, Thomas HC et al (1978) In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1:305–307CrossRefPubMed Vincent A, Scadding GK, Thomas HC et al (1978) In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1:305–307CrossRefPubMed
42.
Zurück zum Zitat Weissferdt A, Moran CA (2015) Mediastinal seminoma with florid follicular lymphoid hyperplasia: a clinicopathological and immunohistochemical study of six cases. Virchows Arch 466:209–215CrossRefPubMed Weissferdt A, Moran CA (2015) Mediastinal seminoma with florid follicular lymphoid hyperplasia: a clinicopathological and immunohistochemical study of six cases. Virchows Arch 466:209–215CrossRefPubMed
43.
Zurück zum Zitat Weissferdt A, Moran CA (2012) Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five cases. Mod Pathol 25:993–999CrossRefPubMed Weissferdt A, Moran CA (2012) Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five cases. Mod Pathol 25:993–999CrossRefPubMed
44.
Zurück zum Zitat Weissferdt A, Moran CA (2012) Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a clinicopathologic and immunohistochemical study of 4 cases. Am J Clin Pathol 138:816–822CrossRefPubMed Weissferdt A, Moran CA (2012) Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a clinicopathologic and immunohistochemical study of 4 cases. Am J Clin Pathol 138:816–822CrossRefPubMed
46.
Zurück zum Zitat Zisimopoulou P, Evangelakou P, Tzartos J et al (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139–145CrossRefPubMed Zisimopoulou P, Evangelakou P, Tzartos J et al (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139–145CrossRefPubMed
Metadaten
Titel
„Echte Thymushyperplasie“
Differenzialdiagnose der Thymusvergrößerung bei Säuglingen und Kindern
verfasst von
Dr. C.‑A. Weis
B. Märkl
T. Schuster
K. Vollert
P. Ströbel
A. Marx
Publikationsdatum
20.04.2017
Verlag
Springer Medizin
Erschienen in
Die Pathologie / Ausgabe 4/2017
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196
DOI
https://doi.org/10.1007/s00292-017-0283-z

Weitere Artikel der Ausgabe 4/2017

Der Pathologe 4/2017 Zur Ausgabe

Schwerpunkt: Kinderpathologie

Leberbiopsie bei Kindern und Jugendlichen

Schwerpunkt: Kinderpathologie

Solide Kindertumoren

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.